Mesecar, Andrew D

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Modified Chloropyridyl Ester Derivates as Anti-Mpro Inhibitors for Covid-19 Treatment
2021-GHOS-69204
  1. Pharmaceuticals
  2. Chemistry and Chemical Analysis
Ghosh, Arun K
Modified Alpha-ketoamide Derivates as anti-Mpro inhibitors for Covid-19 treatment
2021-GHOS-69205
  1. Pharmaceuticals
  2. Chemistry and Chemical Analysis
Ghosh, Arun K
Modified Bis-amide Derivatives as Protease inhibitors for treatment of Covid-19
2021-GHOS-69206
  1. Pharmaceuticals
  2. Chemistry and Chemical Analysis
Ghosh, Arun K
Selective Ubiquitin Specific Protease Inhibitors for Treatment of Multiple Myeloma and Other Cancers
2017-PEPE-67704
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Pepe, Antonella
Facile Expression and Purification of USP17 for use in Cancer Drug Discovery
2016-MESE-67455
  1. Biotechnology
  2. Medical/Health
Mesecar, Andrew D
Library of Broad-Spectrum Coronavirus Therapeutics
2016-STJO-67409
  1. Pharmaceuticals
Mesecar, Andrew D

Details

Dr. Andrew D. Mesecar is the Walther Professor of Cancer Structural Biology and a Professor of Biochemistry (by courtesy) at Purdue University. Dr. Mesecar received a B.S. in Chemistry from Purdue University and a Ph.D. in Biochemistry from the University of Notre Dame. His Post Doctorate was at the University of California, Berkeley. His lab gained recognition among the U.S. Department of Defense by becoming a part of the Defense Science Study Group between 2006 and 2008. Dr. Mesecar's research interests include understanding the ability of proteins and enzymes to recognize their substrates. By understanding this, they can develop therapeutics for treating cancer and infectious diseases.

For additional information, visit Dr. Mesecar's Purdue Biological Sciences website: https://www.bio.purdue.edu/People/faculty_dm/directory.php?refID=770
or his Purdue Chemistry website: https://www.chem.purdue.edu/people/directory/faculty/details/91